Printer-friendly versionPrinter-friendly version

Hepatitis B and C - An Action Plan for Saving Lives in Europe

Over the past four decades, we have seen a significant increase in people across Europe being affected by hepatitis B and C; both serious, asymptomatic, infectious diseases that kill around 120,000 people in Europe every year.1 In response to this, a large body of work has been produced over the past three years, giving information and recommendations on how to address the burden of the disease.

In 2014, leading experts, institutions, patient organisations and pharmaceutical industry representatives met and agreed that the major recommendations produced between 2011 and 2014 should be compiled into one comprehensive document, Hepatitis B and C - An Action Plan for Saving Lives in Europe, to make it easier for policy makers, decision makers, civil society organisations and healthcare institutions to tackle viral hepatitis effectively.

Tags: